Reduced expression of the retinoblastoma protein shows that the related signaling pathway is essential for mediating the antineoplastic activity of erufosine.
Erufosine is a new antineoplastic agent of the group of alkylphosphocholines, which interferes with signal transduction and induces apoptosis in various leukemic and tumor cell lines. The present study was designed to examine for the first time the mechanism of resistance to erufosine in malignant c...
Saved in:
Main Authors: | Maya M Zaharieva, Milen Kirilov, Minquang Chai, Stefan M Berger, Spiro Konstantinov, Martin R Berger |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/b1d12f7a84f64cbf9ebb18b8f19d9578 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antineoplastics Encapsulated in Nanostructured Lipid Carriers
by: Gustavo Henrique Rodrigues da Silva, et al.
Published: (2021) -
Retinoblastoma
by: Marchevsky,Silvia, et al.
Published: (1979) -
Tumor targeting using liposomal antineoplastic drugs
by: Jörg Huwyler, et al.
Published: (2008) -
Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
by: Shu Wen, et al.
Published: (2021) -
The Interference of COVID-19 in the Oral Cancer Diagnosis and Antineoplastic Treatment
by: Correia-Neto,Ivan José, et al.
Published: (2021)